Clinical trials: Contraception Use, open to volunteers
Contraception Use
Flo Digital Contraceptive Study
The goal of this clinical trial is to learn if the Flo Digital Contraceptive (FDC) app can effectively prevent unintended pregnancy in women aged 18 years and older residing in the United States.
- Trial name
- FDC (NCT07630064)
- Testing
- Flo Digital Contraceptive
- Where
- United States
- Volunteers
- 3,800 people
- Sponsor
- Flo Health Inc.
Cancer, Cancer in Pregnancy
ProspectiveFemaleAYA - Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes
In the past two decades, the evidence-based knowledge on the prevalence and risk factors for gonads impairment, including infertility, following cancer and numerous cancer treatment regimen has significantly increased.
- Conditions
- Cancer, Cancer in Pregnancy, Infertility, In Vitro Fertilisation (IVF) Treatment
- Trial name
- FemFertilAYA (NCT07622420)
- Volunteers
- 3,000 people
- Sponsor
- Karolinska Institutet
Substance Use Disorders, Pregnancy Related
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.
- Conditions
- Substance Use Disorders, Pregnancy Related, Contraception
- Trial name
- IMPACT (NCT04939012)
- Testing
- MyPath Intervention, Usual care
- Where
- United States
- Volunteers
- 400 people
- Sponsor
- University of Pittsburgh
Contraception, Pharmaceutical Services
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1.
- Conditions
- Contraception, Pharmaceutical Services, Access and Linkage to Healthcare, Technology Use
- Trial name
- HAPPI (NCT06823037)
- Testing
- HAPPI software
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- EMPOWERX INC
Contraception Use
Sildosin as a Male Contraceptive Non Hormonal
In all, 200 healthy, sexually active, fertile male candidates will be assigned 100 in silodosin group and 100 in placebo group. Males using other contraceptive methods will be excluded.
- Trial name
- NCT07195097
- Testing
- Oral intake of sildosin
- Volunteers
- 200 people
- Sponsor
- Benha University